TY  - JOUR

T1  - Improved tumor response and survival outcomes with post-transplant bortezomib (Btz) consolidation versus observation (Obs) alone in patients with newly diagnosed multiple myeloma (MM): Results from a randomized, open-label, multicenter, parallel-group phase 2 study

JO  - Clinical Lymphoma Myeloma and Leukemia

PY  - 2015/09/08

AU  - Sezer O

AU  - Terpos E

AU  - Hajek R

AU  - Sucak G

AU  - Cagirgan S

AU  - Linkesch W

AU  - Akay OM

AU  - Armbrecht G

AU  - Plesner T

AU  - Snowden JA

AU  - Nahi H et al

ED  - 

DO  - DOI: 10.1016/j.clml.2015.07.323

PB  - Elsevier BV

VL  - 15

SP  - e129

EP  - e130

Y2  - 2024/12/22

ER  -